{
    "clinical_study": {
        "@rank": "153198", 
        "acronym": "TNS-FMA", 
        "arm_group": [
            {
                "arm_group_label": "Trigeminal nerve stimulation - active", 
                "arm_group_type": "Experimental", 
                "description": "10-day TNS interventional protocol  over an 10-day follow-up"
            }, 
            {
                "arm_group_label": "Trigeminal nerve stimulation", 
                "arm_group_type": "Sham Comparator", 
                "description": "10-day sham interventional protocol  over an 10-day follow-up"
            }
        ], 
        "brief_summary": {
            "textblock": "To the investigators knowledge there are no studies of Trigeminal Nerve Stimulation (TNS)\n      for fibromyalgia. TNS may modify overlapping mood and fibromyalgia pain regulation\n      circuitry. The investigators hypothesized that patients with fibromyalgia might experience a\n      clinically significant reduction in daily pain if investigators were to administer TNS in a\n      manner similar to experimental antidepressant protocols."
        }, 
        "brief_title": "Trigeminal Nerve Stimulation (TNS) in the Treatment of Fibromyalgia", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Fibromyalgia", 
        "condition_browse": {
            "mesh_term": [
                "Fibromyalgia", 
                "Myofascial Pain Syndromes"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  We will adopt the following inclusion criteria: (1) patients between 18 and 69 years;\n             (2) patients with a diagnosis of fibromyalgia according to a trained phisycian; (3)\n             score greater than or equal to 5 on the VAS for pain; (4) agreement to participate in\n             the study as recommended in the IC.\n\n        Exclusion Criteria:\n\n          -  Exclusion criteria we cite: (1) patients with psychiatric hospitalization indicated;\n             (2) patients with psychiatric comorbidity; (3) patients with a diagnosis of\n             personality disorder; (4) presence of severe neurological or medical diseases such as\n             neoplasms in activity, neurodegenerative diseases and chronic decompensated."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "69 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02120690", 
            "org_study_id": "TNS-FMA"
        }, 
        "intervention": {
            "arm_group_label": [
                "Trigeminal nerve stimulation - active", 
                "Trigeminal nerve stimulation"
            ], 
            "description": "10-day TNS interventional protocol  over an 10-day follow-up. Subjects will have electrodes (Superior Silver 1.25-in. diameter) placed on their foreheads to stimulate the V1 branches of the trigeminal nerve bilaterally for approximately 30 minutes each day. Current was adjusted to maintain comfortable but perceptible levels of stimulation", 
            "intervention_name": "Trigeminal nerve stimulation", 
            "intervention_type": "Device", 
            "other_name": "Trigeminal nerve stimulation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "pain", 
            "fibromyagia", 
            "TNS"
        ], 
        "lastchanged_date": "April 22, 2014", 
        "location": {
            "contact": {
                "email": "pedroshiozawa@gmail.com", 
                "last_name": "Pedro Shiozawa, MD", 
                "phone": "55 11 34662100"
            }, 
            "contact_backup": {
                "last_name": "Pedro Shiozawa"
            }, 
            "facility": {
                "address": {
                    "city": "sao Paulo", 
                    "country": "Brazil", 
                    "state": "sP", 
                    "zip": "04017030"
                }, 
                "name": "Centro de Atencao Integrada \u00e0 Sa\u00fade Mental"
            }, 
            "investigator": {
                "last_name": "Pedro Shiozawa", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Trigeminal Nerve Stimulation (TNS) as a Complementary Strategy in the Treatment of Fibromyalgia, Open Label Study", 
        "overall_official": [
            {
                "affiliation": "Clinical Neuromodulation Laboratory - Santa Casa Medical School", 
                "last_name": "Pedro Shiozawa, MD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Department of Anestesiology - ISCMSP", 
                "last_name": "Marcelo V Perez, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Department of Psychiatry - ISCMSP", 
                "last_name": "Quirino Corderio, MD, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Health Surveillance Agency", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1/Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Comparison between VAS for pain after intervention protocol and baseline score", 
            "measure": "VAS for pain", 
            "safety_issue": "No", 
            "time_frame": "10 day-follow up"
        }, 
        "reference": [
            {
                "PMID": "21794655", 
                "citation": "Collado A, Conesa A. [Pharmacologic treatment of fibromyalgia: Towards chemical neuromodulation]. Reumatol Clin. 2009 Aug;5 Suppl 2:27-31. doi: 10.1016/j.reuma.2009.04.003. Epub 2009 Jul 9. Spanish."
            }, 
            {
                "PMID": "23819466", 
                "citation": "Tzabazis A, Aparici CM, Rowbotham MC, Schneider MB, Etkin A, Yeomans DC. Shaped magnetic field pulses by multi-coil repetitive transcranial magnetic stimulation (rTMS) differentially modulate anterior cingulate cortex responses and pain in volunteers and fibromyalgia patients. Mol Pain. 2013 Jul 2;9(1):33. [Epub ahead of print]"
            }, 
            {
                "PMID": "21764215", 
                "citation": "Short EB, Borckardt JJ, Anderson BS, Frohman H, Beam W, Reeves ST, George MS. Ten sessions of adjunctive left prefrontal rTMS significantly reduces fibromyalgia pain: a randomized, controlled pilot study. Pain. 2011 Nov;152(11):2477-84. Epub 2011 Jul 20."
            }, 
            {
                "PMID": "12759293", 
                "citation": "Ozgocmen S, Yoldas T, Kamanli A, Yildizhan H, Yigiter R, Ardicoglu O. Auditory P300 event related potentials and serotonin reuptake inhibitor treatment in patients with fibromyalgia. Ann Rheum Dis. 2003 Jun;62(6):551-5."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02120690"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Santa Casa Medical School", 
            "investigator_full_name": "Pedro Shiozawa", 
            "investigator_title": "Coordinator - Laboratory of Clinical Neuromodualtion", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Santa Casa Medical School", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Santa Casa Medical School", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}